Caregiver-Based Fall Prevention Education in Patients Undergoing Awake Deep Brain Stimulation (CARE-DBS-FALL)

November 11, 2026 updated by: Halic University

The Effect of Caregiver-Based Fall Prevention Education on Fall Prevention Behaviors and Fall Rates in Patients Undergoing Awake Deep Brain Stimulation: A Randomized Controlled Trial

Awake deep brain stimulation (DBS) is an effective surgical treatment for Parkinson's disease and other movement disorders, but patients remain at high risk of falls after surgery because of gait disturbance, postural instability, cognitive decline and transient postoperative delirium. Primary caregivers are the people in closest contact with these patients before surgery and after discharge, yet no caregiver-based fall prevention approach specific to this group has been tested. This single-center, parallel-group randomized controlled trial aims to evaluate the effect of an AI-supported structured fall prevention education given to primary caregivers before surgery on caregivers' fall prevention behaviors and on patients' postoperative falls and near-falls. Sixty-four patient-primary caregiver dyads will be randomized 1:1 to education plus usual care or usual care alone. Caregiver behaviors will be observed from postoperative day 0 to day 7 (or until discharge) using a structured observation form.

Study Overview

Detailed Description

This is a single-center, two-arm, parallel-group randomized controlled trial with a 1:1 allocation ratio, conducted at the Neurosurgery Clinic of Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. The unit of randomization is the patient-primary caregiver dyad; each patient and his/her primary caregiver are assigned to the same group, and only one primary caregiver is enrolled per patient.

Sample size was calculated with G*Power 3.1.9.7 based on a similar randomized controlled trial of caregiver fall prevention education (Wang, Zou & Wang, 2022). Because the reported effect size was large (Cohen's d = 1.14), a more conservative d = 0.80 was used with two-sided alpha = 0.05, 80% power and 1:1 allocation, giving 26 dyads per group (52 in total). Allowing for 15% attrition (dropout, change of primary caregiver, missing observations), 32 dyads per group (64 dyads; 64 patients and 64 caregivers, 128 participants) will be enrolled.

Randomization: Dyads will be allocated by computer-generated block randomization (block size 4) by an independent researcher not involved in recruitment, education or data collection. Allocation concealment will be ensured with sequentially numbered, opaque, sealed envelopes prepared by the same independent researcher; the envelope is opened after written informed consent is obtained and the Patient and Primary Caregiver Descriptive Information Form is completed.

Intervention: In addition to routine clinical care, primary caregivers in the experimental group will receive AI-supported structured fall prevention education in the preoperative period. The content, prepared according to current fall prevention literature, covers safe support during first mobilization, bed-chair transfer, walking and toileting, control of environmental risks, and safe use of assistive walking devices. Education will be delivered face to face by the same researcher, with the same content and materials, in a room separate from patient rooms to minimize contamination between groups. The control group will receive routine clinical care only; for ethical reasons, the education content will be offered to control-group caregivers after data collection is completed.

Data collection: The Patient and Primary Caregiver Descriptive Information Form (26 items) will be completed by face-to-face interview before surgery. Caregivers' fall prevention behaviors will be assessed with the Caregiver Fall Prevention Behavior Observation Form (18 behaviors in 4 sections: first mobilization, bed-chair transfer, corridor walking, assistance with toileting and return; each scored 0-2; content validity assessed by 10 experts). First mobilization is observed on postoperative day 0, and the other three sections daily on postoperative days 1-7 (or until discharge if earlier). Falls and near-falls are recorded for each section and day. Observations are performed simultaneously and independently by two trained observers; if a fall risk arises during observation, observers intervene to ensure patient safety and the event is recorded as a near-fall.

Analysis: Data will be analyzed with IBM SPSS by an independent statistician blinded to group allocation, following the intention-to-treat principle, with 95% confidence intervals and p < 0.05. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total divided by the number of observed behaviors; range 0-2) will be used, and its change over time will be analyzed with linear mixed-effects models (group, time and group-by-time interaction). Fall and near-fall counts will be analyzed with Poisson or, if needed, negative binomial regression. Inter-observer agreement will be assessed with weighted Cohen's kappa and intraclass correlation coefficient. Reporting will follow the CONSORT statement.

Study Type

Interventional

Enrollment (Estimated)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Basaksehir
      • Istanbul, Basaksehir, Turkey (Türkiye), 34480
        • Basaksehir Cam and Sakura City Hospital, Neurosurgery Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

Patients:

  • Aged 18 years or older
  • Scheduled for awake deep brain stimulation surgery
  • Able to communicate in Turkish
  • Having a primary caregiver who will accompany the patient during the hospital stay
  • Agreeing to participate in the study

Primary caregivers:

  • Aged 18 years or older
  • Being the patient's primary caregiver
  • Taking part in the patient's care and the planned observations during the postoperative hospital stay
  • Able to read and write in Turkish
  • Agreeing to participate in the study

Exclusion Criteria:

Patients:

  • Need for prolonged intensive care after surgery
  • Development of a serious clinical complication preventing the planned mobilization and observations
  • Transfer to another institution before completion of the study
  • Request of the patient or legal representative to withdraw from the study

Primary caregivers:

  • Not completing the structured education program (experimental group)
  • Being unable to continue accompanying the patient in hospital
  • Change of the primary caregiver during the study
  • Request to withdraw from the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Caregiver Fall Prevention Education

Primary caregivers receive AI-supported structured fall prevention education, delivered face to face in the preoperative period, in addition to the clinic's routine care and information.

Face-to-face structured education delivered by the same researcher to the primary caregiver before awake DBS surgery, using standardized AI-supported materials prepared according to current fall prevention literature. Content: safe support of the patient during first mobilization, bed-chair transfer, walking and toileting; control of environmental fall risks; and safe use of assistive walking devices. Education is given in a room separate from patient rooms.

No Intervention: Usual Care

Patient-caregiver dyads receive only the clinic's routine care and information. For ethical reasons, the education content will be offered to caregivers after data collection is completed.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Mean Caregiver Fall Prevention Behavior Score
Time Frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Measured with the Caregiver Fall Prevention Behavior Observation Form developed by the researchers (18 behaviors in 4 sections: first mobilization [5], bed-chair transfer [4], corridor walking [5], assistance with toileting and return [4]). Each behavior is scored 0 = not performed/performed incorrectly, 1 = partially correct, 2 = fully correct; behaviors not observed or not required on a given day are coded as not observed and excluded. Because the number of applicable behaviors differs between days, the daily mean behavior score (daily total score divided by the number of observed behaviors; range 0-2) is used to assess change over time; higher scores indicate more accurate and complete fall prevention behaviors. Observations are made independently by two trained observers.

Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of Patient Falls During Postoperative Hospitalization
Time Frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Number and rate of patient falls observed during the postoperative hospital stay, recorded as yes/no for each observed activity and day on the Caregiver Fall Prevention Behavior Observation Form.

Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)
Number of Near-Fall Events During Postoperative Hospitalization
Time Frame: Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Number and rate of near-fall events (situations in which a fall risk arose and the observers intervened to ensure patient safety) during the postoperative hospital stay.

Postoperative day 0 through postoperative day 7 (or until discharge, if earlier)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Emine Güngör Turan, MSc, Specialist Nurse, Başakşehir Çam & Sakura City Hospital
  • Study Chair: Fatma Eti Aslan, Prof. Dr., Bahçeşehir University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

March 15, 2027

Study Completion (Estimated)

March 15, 2027

Study Registration Dates

First Submitted

November 11, 2026

First Submitted That Met QC Criteria

November 11, 2026

First Posted (Actual)

November 17, 2026

Study Record Updates

Last Update Posted (Actual)

November 17, 2026

Last Update Submitted That Met QC Criteria

November 11, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • HALIC-2026-DBS-FALL
  • KAEK-326 (Other Identifier: Basaksehir Cam and Sakura City Hospital Clinical Research Ethics Committee)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared in order to protect participant confidentiality.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe